+1 347 708 0418
The Bio-pharma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bio-pharma size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Bio-pharma market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bio-pharma market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Market segment by Application can be divided into
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
The key market players for global Bio-pharma market are listed below:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Bio-pharma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bio-pharma, with price, sales, revenue and global market share of Bio-pharma from 2019 to 2021.
Chapter 3, the Bio-pharma competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bio-pharma breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Bio-pharma market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Bio-pharma sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Bio-pharma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bio-pharma Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.5 Interferons
1.2.6 Recombinant Human Insulin
1.2.7 Erythropoietin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Purified Proteins
1.2.11 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Bio-pharma Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 Global Bio-pharma Market Size & Forecast
1.4.1 Global Bio-pharma Sales in Value (2016-2026))
1.4.2 Global Bio-pharma Sales in Volume (2016-2026)
1.4.3 Global Bio-pharma Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Bio-pharma Production Capacity Analysis
1.5.1 Global Bio-pharma Total Production Capacity (2016-2026)
1.5.2 Global Bio-pharma Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bio-pharma Market Drivers
1.6.2 Bio-pharma Market Restraints
1.6.3 Bio-pharma Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Bio-pharma Product and Services
2.1.4 Pfizer Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 F. Hoffmann-La Roche AG
2.2.1 F. Hoffmann-La Roche AG Details
2.2.2 F. Hoffmann-La Roche AG Major Business
2.2.3 F. Hoffmann-La Roche AG Bio-pharma Product and Services
2.2.4 F. Hoffmann-La Roche AG Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Johnson & Johnson Services
2.3.1 Johnson & Johnson Services Details
2.3.2 Johnson & Johnson Services Major Business
2.3.3 Johnson & Johnson Services Bio-pharma Product and Services
2.3.4 Johnson & Johnson Services Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sanofi, Amgen
2.4.1 Sanofi, Amgen Details
2.4.2 Sanofi, Amgen Major Business
2.4.3 Sanofi, Amgen Bio-pharma Product and Services
2.4.4 Sanofi, Amgen Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Bio-pharma Product and Services
2.5.4 AbbVie Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merck & Co., Inc
2.6.1 Merck & Co., Inc Details
2.6.2 Merck & Co., Inc Major Business
2.6.3 Merck & Co., Inc Bio-pharma Product and Services
2.6.4 Merck & Co., Inc Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Biogen Idec
2.7.1 Biogen Idec Details
2.7.2 Biogen Idec Major Business
2.7.3 Biogen Idec Bio-pharma Product and Services
2.7.4 Biogen Idec Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business
2.8.3 Bayer AG Bio-pharma Product and Services
2.8.4 Bayer AG Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Eli Lilly and Company
2.9.1 Eli Lilly and Company Details
2.9.2 Eli Lilly and Company Major Business
2.9.3 Eli Lilly and Company Bio-pharma Product and Services
2.9.4 Eli Lilly and Company Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Novartis AG GlaxoSmithKline Plc
2.10.1 Novartis AG GlaxoSmithKline Plc Details
2.10.2 Novartis AG GlaxoSmithKline Plc Major Business
2.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Product and Services
2.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Bristol-Myers Squibb Company
2.11.1 Bristol-Myers Squibb Company Details
2.11.2 Bristol-Myers Squibb Company Major Business
2.11.3 Bristol-Myers Squibb Company Bio-pharma Product and Services
2.11.4 Bristol-Myers Squibb Company Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 AstraZeneca PLC
2.12.1 AstraZeneca PLC Details
2.12.2 AstraZeneca PLC Major Business
2.12.3 AstraZeneca PLC Bio-pharma Product and Services
2.12.4 AstraZeneca PLC Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Abbott Laboratories
2.13.1 Abbott Laboratories Details
2.13.2 Abbott Laboratories Major Business
2.13.3 Abbott Laboratories Bio-pharma Product and Services
2.13.4 Abbott Laboratories Bio-pharma Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Bio-pharma Sales by Manufacturer
3.1 Global Bio-pharma Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Bio-pharma Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Bio-pharma
3.4 Market Concentration Rate
3.4.1 Top 3 Bio-pharma Manufacturer Market Share
3.4.2 Top 6 Bio-pharma Manufacturer Market Share
3.5 Global Bio-pharma Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Bio-pharma Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bio-pharma Market Size by Region
4.1.1 Global Bio-pharma Sales in Volume by Region (2016-2026)
4.1.2 Global Bio-pharma Revenue by Region (2016-2026)
4.2 North America Bio-pharma Revenue (2016-2026)
4.3 Europe Bio-pharma Revenue (2016-2026)
4.4 Asia-Pacific Bio-pharma Revenue (2016-2026)
4.5 South America Bio-pharma Revenue (2016-2026)
4.6 Middle East and Africa Bio-pharma Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Bio-pharma Sales in Volume by Type (2016-2026)
5.2 Global Bio-pharma Revenue by Type (2016-2026)
5.3 Global Bio-pharma Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Bio-pharma Sales in Volume by Application (2016-2026)
6.2 Global Bio-pharma Revenue by Application (2016-2026)
6.3 Global Bio-pharma Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Bio-pharma Sales by Type (2016-2026)
7.2 North America Bio-pharma Sales by Application (2016-2026)
7.3 North America Bio-pharma Market Size by Country
7.3.1 North America Bio-pharma Sales in Volume by Country (2016-2026)
7.3.2 North America Bio-pharma Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Bio-pharma Sales by Type (2016-2026)
8.2 Europe Bio-pharma Sales by Application (2016-2026)
8.3 Europe Bio-pharma Market Size by Country
8.3.1 Europe Bio-pharma Sales in Volume by Country (2016-2026)
8.3.2 Europe Bio-pharma Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Bio-pharma Sales by Type (2016-2026)
9.2 Asia-Pacific Bio-pharma Sales by Application (2016-2026)
9.3 Asia-Pacific Bio-pharma Market Size by Region
9.3.1 Asia-Pacific Bio-pharma Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Bio-pharma Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Bio-pharma Sales by Type (2016-2026)
10.2 South America Bio-pharma Sales by Application (2016-2026)
10.3 South America Bio-pharma Market Size by Country
10.3.1 South America Bio-pharma Sales in Volume by Country (2016-2026)
10.3.2 South America Bio-pharma Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bio-pharma Sales by Type (2016-2026)
11.2 Middle East & Africa Bio-pharma Sales by Application (2016-2026)
11.3 Middle East & Africa Bio-pharma Market Size by Country
11.3.1 Middle East & Africa Bio-pharma Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Bio-pharma Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Bio-pharma Typical Distributors
12.3 Bio-pharma Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Bio-pharma Revenue by Type, (USD Million), 2021-2026
Table 2. Global Bio-pharma Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Bio-pharma Product and Services
Table 6. Pfizer Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche AG Major Business
Table 9. F. Hoffmann-La Roche AG Bio-pharma Product and Services
Table 10. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Services Major Business
Table 13. Johnson & Johnson Services Bio-pharma Product and Services
Table 14. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi, Amgen Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi, Amgen Major Business
Table 17. Sanofi, Amgen Bio-pharma Product and Services
Table 18. Sanofi, Amgen Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AbbVie Basic Information, Manufacturing Base and Competitors
Table 20. AbbVie Major Business
Table 21. AbbVie Bio-pharma Product and Services
Table 22. AbbVie Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 24. Merck & Co., Inc Major Business
Table 25. Merck & Co., Inc Bio-pharma Product and Services
Table 26. Merck & Co., Inc Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 28. Biogen Idec Major Business
Table 29. Biogen Idec Bio-pharma Product and Services
Table 30. Biogen Idec Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 32. Bayer AG Major Business
Table 33. Bayer AG Bio-pharma Product and Services
Table 34. Bayer AG Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly and Company Major Business
Table 37. Eli Lilly and Company Bio-pharma Product and Services
Table 38. Eli Lilly and Company Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis AG GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 40. Novartis AG GlaxoSmithKline Plc Major Business
Table 41. Novartis AG GlaxoSmithKline Plc Bio-pharma Product and Services
Table 42. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myers Squibb Company Major Business
Table 45. Bristol-Myers Squibb Company Bio-pharma Product and Services
Table 46. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 48. AstraZeneca PLC Major Business
Table 49. AstraZeneca PLC Bio-pharma Product and Services
Table 50. AstraZeneca PLC Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. Abbott Laboratories Major Business
Table 53. Abbott Laboratories Bio-pharma Product and Services
Table 54. Abbott Laboratories Bio-pharma Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Bio-pharma Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 56. Global Bio-pharma Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Bio-pharma, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Bio-pharma Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Bio-pharma Production Site of Key Manufacturer
Table 60. Bio-pharma New Entrant and Capacity Expansion Plans
Table 61. Bio-pharma Mergers & Acquisitions in the Past Five Years
Table 62. Global Bio-pharma Sales by Region (2016-2021e) & (K Pcs)
Table 63. Global Bio-pharma Sales by Region (2021-2026) & (K Pcs)
Table 64. Global Bio-pharma Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Bio-pharma Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Bio-pharma Sales by Type (2016-2021e) & (K Pcs)
Table 67. Global Bio-pharma Sales by Type (2021-2026) & (K Pcs)
Table 68. Global Bio-pharma Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Bio-pharma Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Bio-pharma Price by Type (2016-2021e) & (USD/Pcs)
Table 71. Global Bio-pharma Price by Type (2021-2026) & (USD/Pcs)
Table 72. Global Bio-pharma Sales by Application (2016-2021e) & (K Pcs)
Table 73. Global Bio-pharma Sales by Application (2021-2026) & (K Pcs)
Table 74. Global Bio-pharma Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Bio-pharma Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Bio-pharma Price by Application (2016-2021e) & (USD/Pcs)
Table 77. Global Bio-pharma Price by Application (2021-2026) & (USD/Pcs)
Table 78. North America Bio-pharma Sales by Country (2016-2021e) & (K Pcs)
Table 79. North America Bio-pharma Sales by Country (2021-2026) & (K Pcs)
Table 80. North America Bio-pharma Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Bio-pharma Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Bio-pharma Sales by Type (2016-2021e) & (K Pcs)
Table 83. North America Bio-pharma Sales by Type (2021-2026) & (K Pcs)
Table 84. North America Bio-pharma Sales by Application (2016-2021e) & (K Pcs)
Table 85. North America Bio-pharma Sales by Application (2021-2026) & (K Pcs)
Table 86. Europe Bio-pharma Sales by Country (2016-2021e) & (K Pcs)
Table 87. Europe Bio-pharma Sales by Country (2021-2026) & (K Pcs)
Table 88. Europe Bio-pharma Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Bio-pharma Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Bio-pharma Sales by Type (2016-2021e) & (K Pcs)
Table 91. Europe Bio-pharma Sales by Type (2021-2026) & (K Pcs)
Table 92. Europe Bio-pharma Sales by Application (2016-2021e) & (K Pcs)
Table 93. Europe Bio-pharma Sales by Application (2021-2026) & (K Pcs)
Table 94. Asia-Pacific Bio-pharma Sales by Region (2016-2021e) & (K Pcs)
Table 95. Asia-Pacific Bio-pharma Sales by Region (2021-2026) & (K Pcs)
Table 96. Asia-Pacific Bio-pharma Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Bio-pharma Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Bio-pharma Sales by Type (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Bio-pharma Sales by Type (2021-2026) & (K Pcs)
Table 100. Asia-Pacific Bio-pharma Sales by Application (2016-2021e) & (K Pcs)
Table 101. Asia-Pacific Bio-pharma Sales by Application (2021-2026) & (K Pcs)
Table 102. South America Bio-pharma Sales by Country (2016-2021e) & (K Pcs)
Table 103. South America Bio-pharma Sales by Country (2021-2026) & (K Pcs)
Table 104. South America Bio-pharma Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Bio-pharma Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Bio-pharma Sales by Type (2016-2021e) & (K Pcs)
Table 107. South America Bio-pharma Sales by Type (2021-2026) & (K Pcs)
Table 108. South America Bio-pharma Sales by Application (2016-2021e) & (K Pcs)
Table 109. South America Bio-pharma Sales by Application (2021-2026) & (K Pcs)
Table 110. Middle East & Africa Bio-pharma Sales by Country (2016-2021e) & (K Pcs)
Table 111. Middle East & Africa Bio-pharma Sales by Country (2021-2026) & (K Pcs)
Table 112. Middle East & Africa Bio-pharma Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Bio-pharma Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Bio-pharma Sales by Type (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Bio-pharma Sales by Type (2021-2026) & (K Pcs)
Table 116. Middle East & Africa Bio-pharma Sales by Application (2016-2021e) & (K Pcs)
Table 117. Middle East & Africa Bio-pharma Sales by Application (2021-2026) & (K Pcs)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Bio-pharma Typical Distributors
Table 121. Bio-pharma Typical Customers
List of Figures
Figure 1. Bio-pharma Picture
Figure 2. Global Bio-pharma Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Recombinant Proteins
Figure 5. Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 6. Interferons
Figure 7. Recombinant Human Insulin
Figure 8. Erythropoietin
Figure 9. Vaccines
Figure 10. Growth Hormones
Figure 11. Purified Proteins
Figure 12. Others
Figure 13. Global Bio-pharma Sales Market Share by Application in 2020
Figure 14. Metabolic Disorders
Figure 15. Oncology
Figure 16. Neurological Disorders
Figure 17. Cardiovascular Diseases
Figure 18. Inflammatory and Infectious Diseases
Figure 19. Others
Figure 20. Global Bio-pharma Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 21. Global Bio-pharma Market Size and Forecast (2016-2026) & (USD Million)
Figure 22. Global Bio-pharma Sales (2016-2026) & (K Pcs)
Figure 23. Global Bio-pharma Price by Type (2016-2026) & (USD/Pcs)
Figure 24. Global Bio-pharma Production Capacity (2016-2026) & (K Pcs)
Figure 25. Global Bio-pharma Production Capacity by Geographic Region: 2020 VS 2021
Figure 26. Bio-pharma Market Drivers
Figure 27. Bio-pharma Market Restraints
Figure 28. Bio-pharma Market Trends
Figure 29. Global Bio-pharma Sales Market Share by Manufacturer in 2020
Figure 30. Global Bio-pharma Revenue Market Share by Manufacturer in 2020
Figure 31. Bio-pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 32. Top 3 Bio-pharma Manufacturer (Revenue) Market Share in 2020
Figure 33. Top 6 Bio-pharma Manufacturer (Revenue) Market Share in 2020
Figure 34. Global Bio-pharma Sales Market Share by Region (2016-2026)
Figure 35. Global Bio-pharma Revenue Market Share by Region (2016-2026)
Figure 36. North America Bio-pharma Revenue (2016-2026) & (USD Million)
Figure 37. Europe Bio-pharma Revenue (2016-2026) & (USD Million)
Figure 38. Asia-Pacific Bio-pharma Revenue (2016-2026) & (USD Million)
Figure 39. South America Bio-pharma Revenue (2016-2026) & (USD Million)
Figure 40. Middle East & Africa Bio-pharma Revenue (2016-2026) & (USD Million)
Figure 41. Global Bio-pharma Sales Market Share by Type (2016-2026)
Figure 42. Global Bio-pharma Revenue Market Share by Type (2016-2026)
Figure 43. Global Bio-pharma Price by Type (2016-2026) & (USD/Pcs)
Figure 44. Global Bio-pharma Sales Market Share by Application (2016-2026)
Figure 45. Global Bio-pharma Revenue Market Share by Application (2016-2026)
Figure 46. Global Bio-pharma Price by Application (2016-2026) & (USD/Pcs)
Figure 47. North America Bio-pharma Sales Market Share by Type (2016-2026)
Figure 48. North America Bio-pharma Sales Market Share by Application (2016-2026)
Figure 49. North America Bio-pharma Sales Market Share by Country (2016-2026)
Figure 50. North America Bio-pharma Revenue Market Share by Country (2016-2026)
Figure 51. United States Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Bio-pharma Sales Market Share by Type (2016-2026)
Figure 55. Europe Bio-pharma Sales Market Share by Application (2016-2026)
Figure 56. Europe Bio-pharma Sales Market Share by Country (2016-2026)
Figure 57. Europe Bio-pharma Revenue Market Share by Country (2016-2026)
Figure 58. Germany Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Bio-pharma Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Bio-pharma Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Bio-pharma Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Bio-pharma Revenue Market Share by Region (2016-2026)
Figure 67. China Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Korea Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Bio-pharma Sales Market Share by Type (2016-2026)
Figure 74. South America Bio-pharma Sales Market Share by Application (2016-2026)
Figure 75. South America Bio-pharma Sales Market Share by Country (2016-2026)
Figure 76. South America Bio-pharma Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East & Africa Bio-pharma Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Bio-pharma Sales Market Share by Application (2016-2026)
Figure 81. Middle East & Africa Bio-pharma Sales Market Share by Country (2016-2026)
Figure 82. Middle East & Africa Bio-pharma Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Egypt Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Saudi Arabia Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. South Africa Bio-pharma Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Figure 88. Methodology
Figure 89. Research Process and Data Source
Buy
